Press Release
Healthcare Materials

Blood Plasma Products Market 2019 analysis by CSL Behring, Shire Plc, Grifols S.A., Octapharma AG, ADMA Biologics, Kedrion Biopharma

Blood Plasma Products Market research report covers industry chain analysis, latest market trends & dynamics along with cost profit analysis of major key players which focuses on expansion rate, prices, competition, size, prices and value chain analysis of those leaders in the market. The report covers the market landscape and its development prospects over the coming years.

The global blood plasma products market is forecasted to grow at a CAGR of 6.8% and will reach USD 28.5 Bn in 2023 from USD 20.5 Bn in 2018. The increasing demand of immunoglobulin for the treatment of immunodeficiency drive the market growth. The blood plasma products market is segmented based on product types like immunoglobulin, albumin, hyperimmune globulin, coagulation factor VIII, coagulation factor IX, and other plasma products. The market is also segmented based on end users such as hospitals, clinics, and other end users. Rise in technology at plasma collection centers to collect plasma and record patient history, and use of dried plasma that reduced cold chain requirements are the major trends in the market that may boost the market growth.

Download Sample PDF copy of this report @ https://www.supplydemandmarketresearch.com/home/contact/483281?ref=Sample-and-Brochure&toccode=SDMRHE483281&utm_source=S2

North America is leading the blood plasma products market and occupied approximately 44.2% of the market in 2018. This is due to the rising incidence of haemophilia, and rapid approval by the FDA for the plasma products. Europe is likely to expand over the forecast period of 2018-2023, by exhibiting a CAGR of 6.6%. This is due to easy access to high-quality plasma through the contributions of qualified donors. Europe is followed by the Asia pacific with a market share of 19.3% in 2018. India and China are the major contributors of plasma products market in the Asia-Pacific region due to a large number of immunodeficient patients to get treated in hospitals and clinics. The Latin America and the Middle-East and Africa markets though, still at nascent stages, will also experience high growth because of the growing prevalence of blood disorders.

Companies covered

CSL Behring

Shire Plc

Grifols S.A.

Octapharma AG

ADMA Biologics

Kedrion Biopharma

Segmentation based on product types

Based on product types, immunoglobulin market has the highest market share (approximately 47%) because of the growing incidence of immunological diseases coupled with the rise in the geriatric population. The market share of albumin was 15.6% in 2018 which is driven by the rise in adoption of albumin in developing countries and an increase in awareness of recombinant albumin but post-operative risks associated with albumin-based therapy may hamper the market growth. Albumin market share is followed by hyperimmune globulin, coagulation factor VIII, and coagulation factor IX in 2018.

Segmentation based on end users

On the basis of end users, the hospital segment dominated the market with a market share of ~82% in 2018. This is due to the increase in the number of hospitals in developing countries and the rise in awareness of diseases like hemophilia. It is followed by clinics with a market share of 14.1% in 2018. The clinics market is driven by the growing number of clinics, increase in awareness among patients regarding plasma products and rise in the number of patients with blood and immunological disorders. Other end users that include research institutes, blood transfusion centers, and academic institutes was having the least market share in 2018.

Enquire before [email protected]: https://www.supplydemandmarketresearch.com/home/purchase?code=SDMRHE483281

Table of Contents:

Chapter  1:  Executive  summary
1.1.  Market  scope  and  segmentation
1.2.  Key  questions  answered  in  the  study
1.3.  Executive  summary

Chapter  2:  Introduction
2.1.  Market  definitions
2.2.  Global  market  trends
2.3.  Global  drivers
2.4.  Global  challenges
2.5.  Revenue  based  on  product  types  –  2018  (USD  Bn)
2.6.  Revenue  based  on  end  users  –  2018  (USD  Bn)
2.7.  Value  chain  of  blood  plasma  products  market

Chapter  3:  Global  Blood  Plasma  Products  Market  Overview
3.1.  Market  overview

Chapter  4:  Global  Blood  Plasma  Products  Market  –  Based  on  Product  Types
4.1.  Global  Immunoglobulin  market
4.2.  Global  Albumin  market
4.3.  Global  Hyperimmune  Globulin  market
4.4.  Global  Coagulation  Factor  VIII  market
4.5.  Global  Coagulation  Factor  IX  market
4.6.  Global  Other  Plasma  Products  market

Chapter  5:  Global  Blood  Plasma  Products  Market  –  Based  on  End  Users
5.1.  Global  Hospitals  market
5.2.  Global  Clinics  market
5.3.  Global  Other  End  Users  market

Chapter  6:  Global  Blood  Plasma  Products  Market  –  Based  on  Regions
6.1.  North  America  market
6.2.  Europe  market
6.3.  Asia-Pacific  market
6.4.  Latin  America  market
6.5.  The  Middle-East  and  Africa  market

Chapter  7:  Competitive  Landscap

…….TOC Continued

About us

We have a strong network of high powered and experienced global consultants who have about 10+ years of experience in the specific industry to deliver quality research and analysis.

Having such an experienced network, our services not only cater to the client who wants the basic reference of market numbers and related high growth areas in the demand side, but also we provide detailed and granular information using which the client can definitely plan the strategies with respect to both supply and demand side.

Canada Office:

302-20 Misssisauga Valley Blvd, Missisauga, L5A 3S1, Toronto

Contact Us

Email- [email protected]

Website- www.supplydemandmarketresearch.com

Phone Number: +919960204545